heart failure

change direction new plan alter arrows move reprioritize
Biotech

AstraZeneca relaxed about relaxin drug's poor efficacy in ph. 2

AstraZeneca executives have told Fierce Biotech they still see potential in harnessing the relaxin hormone to treat heart failure.
heart over ekg

NICE greenlights Abbott's cardiac sensor implant for NHS

Feb 6, 2026 5:45am
Rocket with heart on blue background

Impulse Dynamics clinches $158M for heart failure implant

Dec 12, 2025 11:10am
heart model with cardiologist

FDA panel votes against J&J shunt implant for heart failure

Dec 5, 2025 4:31pm
Silhouette of Businessman Entering Lit Door Passage in Darkness

Cytokinetics doesn't want Big Pharma help to overtake Camzyos

Nov 18, 2025 1:30pm
cardiovascular disease

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Sep 30, 2025 1:55pm